CERT Certara, Inc.
Nasdaq · SEC CIK 1827090 · EDGAR
- Bought, last 12 months
- $200.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 209 since 2021-07-01, latest 2026-09-02 16:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Feehery William F | CEO, Dir | $200.0K | — |
| Bedi Arjun | Dir | — | — |
| Resnick Jon Matthew | CEO, Dir | — | — |
| McKemey Adrian | Pres, Drug Dev. Solutions | — | — |
| Reynders John V W | CFO, Dir | — | — |
| Corcoran Daniel | SVP, GC | — | — |
| Anhalt Rona | CHRO | — | — |
| Aspbury Robert | Pres, PREDICTIVE TECH | — | — |
| Gallagher John E | CFO | — | — |
| Killefer Nancy | Dir | — | — |
Transactions 221
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-23 | CERT | Crane Rosemary A | Dir | M - OptEx | $0.00 | +9,324 | 9,324 | New | $0 |
| D | 2023-05-19 | 2023-05-17 | CERT | Collins Cynthia | Dir | M - OptEx | $0.00 | +9,067 | 15.5K | +141% | $0 |
| D | 2023-05-19 | 2023-05-17 | CERT | WALSH MATTHEW M | Dir | M - OptEx | $0.00 | +9,067 | 177.0K | +5% | $0 |
| D | 2023-05-18 | 2023-05-17 | CERT | Killefer Nancy | Dir | M - OptEx | $0.00 | +9,067 | 15.5K | +141% | $0 |
| D | 2023-05-18 | 2023-05-17 | CERT | CASHMAN JAMES E III | Dir | M - OptEx | $0.00 | +9,067 | 447.8K | +2% | $0 |
| 2023-05-15 | 2023-05-11 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $20.82 | -5,000 | 177.4K | -3% | -$104.1K | |
| 2023-04-17 | 2023-04-14 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $23.66 | -5,000 | 182.4K | -3% | -$118.3K | |
| DM | 2023-04-03 | 2023-03-31 | CERT | Traynor Richard M. | SVP AND GC | F - Tax | $23.80 | -3,847 | 182.8K | -2% | -$91.6K |
| D | 2023-04-03 | 2023-03-31 | CERT | Traynor Richard M. | SVP AND GC | M - OptEx | $0.00 | +6,651 | 189.5K | +4% | $0 |
| D | 2023-04-03 | 2023-03-31 | CERT | Feehery William F | CEO, Dir | M - OptEx | $0.00 | +36.6K | 2.20M | +2% | $0 |
| DM | 2023-04-03 | 2023-03-31 | CERT | Feehery William F | CEO, Dir | F - Tax | $23.80 | -25.6K | 2.16M | -1% | -$610.1K |
| D | 2023-04-03 | 2023-03-31 | CERT | Schemick Michael Andrew | CFO | M - OptEx | $0.00 | +13.3K | 527.5K | +3% | $0 |
| DM | 2023-04-03 | 2023-03-31 | CERT | Schemick Michael Andrew | CFO | F - Tax | $23.80 | -8,277 | 514.1K | -2% | -$197.0K |
| DM | 2023-04-03 | 2023-03-31 | CERT | Pedersen Leif E | Pres, SOFTWARE | F - Tax | $23.80 | -4,039 | 180.1K | -2% | -$96.1K |
| D | 2023-04-03 | 2023-03-31 | CERT | Pedersen Leif E | Pres, SOFTWARE | M - OptEx | $0.00 | +8,646 | 182.2K | +5% | $0 |
| DM | 2023-04-03 | 2023-03-31 | CERT | Aspbury Robert | Pres, SIMCYP | F - Tax | $23.80 | -6,934 | 272.3K | -2% | -$165.0K |
| D | 2023-04-03 | 2023-03-31 | CERT | Aspbury Robert | Pres, SIMCYP | M - OptEx | $0.00 | +8,646 | 281.0K | +3% | $0 |
| D | 2023-04-03 | 2023-03-31 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | M - OptEx | $0.00 | +8,646 | 82.0K | +12% | $0 |
| DM | 2023-04-03 | 2023-03-31 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | F - Tax | $23.80 | -4,426 | 79.1K | -5% | -$105.3K |
| D | 2023-04-03 | 2023-03-31 | CERT | SHERMAN NICOLETTE D | CHRO | F - Tax | $23.80 | -1,251 | 15.5K | -7% | -$29.8K |
| D | 2023-04-03 | 2023-03-31 | CERT | SHERMAN NICOLETTE D | CHRO | M - OptEx | $0.00 | +3,990 | 16.8K | +31% | $0 |
| D | 2023-04-03 | 2023-03-31 | CERT | Virkler Drayton | Pres, REG, ACCES | M - OptEx | $0.00 | +3,990 | 13.6K | +42% | $0 |
| D | 2023-04-03 | 2023-03-31 | CERT | Virkler Drayton | Pres, REG, ACCES | F - Tax | $23.80 | -1,166 | 12.4K | -9% | -$27.8K |
| 2023-03-07 | 2023-03-06 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $21.45 | -10.0K | 184.6K | -5% | -$214.5K | |
| 2023-02-03 | 2023-02-02 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $20.00 | -15.0K | 194.6K | -7% | -$300.0K | |
| I | 2022-12-12 | 2022-12-08 | CERT | EQT Fund Management S.a r.l. | 10% | S - Sale | $15.00 | -29.95M | 0 | -100% | -$449.32M |
| 2022-11-23 | 2022-11-22 | CERT | Pedersen Leif E | Pres, SOFTWARE | S - Sale | $15.55 | -51.2K | 175.5K | -23% | -$796.5K | |
| M | 2022-11-16 | 2022-11-14+ | CERT | SLAINE MASON P | Dir | S - Sale | $15.56 | -250.0K | 660.3K | -27% | -$3.89M |
| 2022-11-15 | 2022-11-14 | CERT | WALSH MATTHEW M | Dir | S - Sale | $14.74 | -12.1K | 167.9K | -7% | -$177.7K | |
| 2022-11-14 | 2022-11-09 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | S - Sale | $13.48 | -2,387 | 74.9K | -3% | -$32.2K | |
| 2022-11-02 | 2022-11-01 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | F - Tax | $12.23 | -1,244 | 77.2K | -2% | -$15.2K | |
| DM | 2022-10-04 | 2022-09-30 | CERT | Virkler Drayton | INTERIM Pres, REG, ACCES | M - OptEx | $0.00 | +13.6K | 13.6K | New | $0 |
| D | 2022-10-04 | 2022-09-30 | CERT | Virkler Drayton | INTERIM Pres, REG, ACCES | F - Tax | $13.31 | -4,004 | 9,591 | -29% | -$53.3K |
| 2022-08-23 | 2022-08-19 | CERT | McLean Stephen M. | Dir | P - Purchase | $16.32 | +20.0K | 42.0K | +91% | +$326.4K | |
| 2022-08-18 | 2022-08-17 | CERT | Schemick Michael Andrew | CFO | P - Purchase | $16.64 | +25.0K | 517.9K | +5% | +$416.0K | |
| 2022-08-18 | 2022-08-16 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | S - Sale | $17.71 | -10.0K | 78.5K | -11% | -$177.1K | |
| I | 2022-08-17 | 2022-08-16 | CERT | EQT Avatar Parent GP LLC | 10% | S - Sale | $17.38 | -6.00M | 29.95M | -17% | -$104.36M |
| 2022-08-17 | 2022-08-16 | CERT | SLAINE MASON P | Dir | S - Sale | $17.38 | -182.5K | 910.3K | -17% | -$3.17M | |
| M | 2022-08-02 | 2022-08-01 | CERT | SHERMAN NICOLETTE D | CHRO | F - Tax | $22.99 | -2,812 | 14.6K | -16% | -$64.6K |
| 2022-07-05 | 2022-07-01 | CERT | Aspbury Robert | Pres, SIMCYP | F - Tax | $21.46 | -884 | 275.2K | -0.3% | -$19.0K | |
| 2022-06-09 | 2022-06-08 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | S - Sale | $19.16 | -10.0K | 88.5K | -10% | -$191.6K | |
| M | 2022-06-03 | 2022-06-02 | CERT | SLAINE MASON P | Dir | S - Sale | $19.56 | -250.0K | 1.09M | -19% | -$4.89M |
| I | 2022-06-01 | 2022-05-31 | CERT | EQT Avatar Parent L.P. | 10% | S - Sale | $19.00 | -1.50M | 35.96M | -4% | -$28.50M |
| D | 2022-04-05 | 2022-04-01 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | F - Tax | $21.48 | -2,326 | 394.8K | -0.6% | -$50.0K |
| D | 2022-04-05 | 2022-04-01 | CERT | Pedersen Leif E | Pres, SOFTWARE | F - Tax | $21.48 | -1,982 | 226.7K | -0.9% | -$42.6K |
| D | 2022-04-05 | 2022-04-01 | CERT | Aspbury Robert | Pres, SIMCYP | F - Tax | $21.48 | -2,870 | 276.1K | -1% | -$61.6K |
| D | 2022-04-05 | 2022-04-01 | CERT | Feehery William F | CEO, Dir | F - Tax | $21.48 | -9,255 | 2.17M | -0.4% | -$198.8K |
| D | 2022-04-05 | 2022-04-01 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | F - Tax | $21.48 | -1,914 | 248.6K | -0.8% | -$41.1K |
| D | 2022-04-05 | 2022-04-01 | CERT | Schemick Michael Andrew | CFO | F - Tax | $21.48 | -3,973 | 492.9K | -0.8% | -$85.3K |
| D | 2022-04-05 | 2022-04-01 | CERT | Traynor Richard M. | SVP AND GC | F - Tax | $21.48 | -1,723 | 209.6K | -0.8% | -$37.0K |
| D | 2022-04-05 | 2022-04-01 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | F - Tax | $21.48 | -1,532 | 101.8K | -1% | -$32.9K |
| D | 2022-04-05 | 2022-04-04 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | S - Sale | $22.29 | -3,352 | 98.5K | -3% | -$74.7K |
| M | 2022-03-18 | 2022-03-16+ | CERT | SLAINE MASON P | Dir | S - Sale | $20.21 | -250.0K | 1.34M | -16% | -$5.05M |
| 2022-03-18 | 2022-03-16 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $20.00 | -3,000 | 211.3K | -1% | -$60.0K | |
| 2022-03-17 | 2022-03-16 | CERT | Feehery William F | CEO, Dir | S - Sale | $20.17 | -62.5K | 2.18M | -3% | -$1.26M | |
| 2022-03-14 | 2022-03-11 | CERT | Feehery William F | CEO, Dir | S - Sale | $20.29 | -27.5K | 2.24M | -1% | -$558.3K | |
| M | 2022-02-22 | 2022-02-18 | CERT | Feehery William F | CEO, Dir | S - Sale | $23.35 | -75.0K | 2.27M | -3% | -$1.75M |
| M | 2022-02-22 | 2022-02-17 | CERT | Feehery William F | CEO, Dir | S - Sale | $24.32 | -90.0K | 2.35M | -4% | -$2.19M |
| M | 2022-02-02 | 2022-02-01 | CERT | SLAINE MASON P | Dir | S - Sale | $26.61 | -50.0K | 1.59M | -3% | -$1.33M |
| M | 2022-01-27 | 2022-01-26 | CERT | Feehery William F | CEO, Dir | S - Sale | $25.37 | -75.0K | 2.48M | -3% | -$1.90M |
| 2022-01-27 | 2022-01-26 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $26.01 | -3,000 | 214.3K | -1% | -$78.0K | |
| 2022-01-21 | 2022-01-20 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $27.50 | -5,000 | 397.1K | -1% | -$137.5K | |
| 2022-01-20 | 2022-01-18 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $27.44 | -5,000 | 217.3K | -2% | -$137.2K | |
| M | 2022-01-04 | 2022-01-03 | CERT | SLAINE MASON P | Dir | S - Sale | $28.63 | -50.0K | 1.65M | -3% | -$1.43M |
| 2021-12-28 | 2021-12-27 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $29.30 | -3,000 | 222.3K | -1% | -$87.9K | |
| 2021-12-27 | 2021-12-23 | CERT | CASHMAN JAMES E III | Dir | S - Sale | $29.20 | -25.1K | 438.8K | -5% | -$733.2K | |
| 2021-12-23 | 2021-12-22 | CERT | CASHMAN JAMES E III | Dir | S - Sale | $29.00 | -19.9K | 463.9K | -4% | -$576.8K | |
| 2021-12-23 | 2021-12-22 | CERT | Feehery William F | CEO, Dir | S - Sale | $28.58 | -75.0K | 2.51M | -3% | -$2.14M | |
| 2021-12-21 | 2021-12-20 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | S - Sale | $28.00 | -7,500 | 250.5K | -3% | -$210.0K | |
| 2021-12-20 | 2021-12-17 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | S - Sale | $26.13 | -5,000 | 258.0K | -2% | -$130.7K | |
| M | 2021-12-14 | 2021-12-13 | CERT | Dir | S - Sale | $28.05 | -50.0K | 1.69M | -3% | -$1.40M | |
| M | 2021-12-08 | 2021-12-07 | CERT | Feehery William F | CEO, Dir | S - Sale | $27.77 | -70.0K | 2.58M | -3% | -$1.94M |
| M | 2021-12-06 | 2021-12-03 | CERT | Feehery William F | CEO, Dir | S - Sale | $26.02 | -70.0K | 2.66M | -3% | -$1.82M |
| M | 2021-11-26 | 2021-11-24 | CERT | Feehery William F | CEO, Dir | S - Sale | $28.43 | -145.0K | 2.72M | -5% | -$4.12M |
| I | 2021-11-24 | 2021-11-22 | CERT | EQT Avatar Parent L.P. | 10% | S - Sale | $29.74 | -8.12M | 37.46M | -18% | -$241.42M |
| 2021-11-24 | 2021-11-22 | CERT | SLAINE MASON P | Dir | S - Sale | $29.74 | -376.1K | 1.74M | -18% | -$11.19M | |
| 2021-11-22 | 2021-11-19 | CERT | Feehery William F | CEO, Dir | S - Sale | $30.31 | -70.0K | 2.87M | -2% | -$2.12M | |
| 2021-11-22 | 2021-11-19 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | S - Sale | $30.30 | -20.0K | 263.0K | -7% | -$606.0K | |
| M | 2021-11-16 | 2021-11-15 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $37.98 | -73.0K | 225.3K | -24% | -$2.77M |
| M | 2021-11-16 | 2021-11-15 | CERT | Schemick Michael Andrew | CFO | S - Sale | $37.84 | -66.7K | 496.8K | -12% | -$2.52M |
| M | 2021-11-15 | 2021-11-11 | CERT | Aspbury Robert | Pres, SIMCYP | S - Sale | $39.56 | -21.6K | 279.0K | -7% | -$852.8K |
| 2021-11-01 | 2021-11-01 | CERT | SMITH PATRICK F | Pres, INTEGRATED DRUG DEV | A - Grant | $0.00 | +3,631 | 103.4K | +4% | $0 | |
| M | 2021-10-28 | 2021-10-27 | CERT | Feehery William F | CEO, Dir | S - Sale | $39.24 | -75.0K | 2.94M | -2% | -$2.94M |
| 2021-10-27 | 2021-10-26 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $39.95 | -3,000 | 402.1K | -0.7% | -$119.9K | |
| 2021-10-27 | 2021-10-26 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $39.95 | -3,000 | 298.3K | -1.0% | -$119.9K | |
| 2021-10-22 | 2021-10-21 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $38.60 | -6,116 | 405.1K | -1% | -$236.1K | |
| 2021-10-21 | 2021-10-20 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $38.58 | -12.7K | 411.2K | -3% | -$489.0K | |
| M | 2021-10-20 | 2021-10-19 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | S - Sale | $38.08 | -20.0K | 301.6K | -6% | -$761.6K |
| 2021-10-20 | 2021-10-19 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $38.55 | -1,210 | 423.9K | -0.3% | -$46.6K | |
| M | 2021-10-19 | 2021-10-18 | CERT | Schemick Michael Andrew | CFO | S - Sale | $36.48 | -66.7K | 568.1K | -11% | -$2.43M |
| 2021-10-18 | 2021-10-15 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $37.38 | -5,000 | 425.1K | -1% | -$186.9K | |
| 2021-10-18 | 2021-10-15 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $37.38 | -5,000 | 301.3K | -2% | -$186.9K | |
| M | 2021-10-04 | 2021-10-01 | CERT | Aspbury Robert | Pres, SIMCYP | S - Sale | $33.51 | -19.4K | 303.3K | -6% | -$648.6K |
| 2021-09-28 | 2021-09-27 | CERT | Edge Justin | Pres, REGULATORY, ACCESS | S - Sale | $36.00 | -3,000 | 430.1K | -0.7% | -$108.0K | |
| 2021-09-28 | 2021-09-27 | CERT | Traynor Richard M. | SVP AND GC | S - Sale | $36.00 | -3,000 | 306.3K | -1.0% | -$108.0K | |
| M | 2021-09-23 | 2021-09-22 | CERT | Feehery William F | CEO, Dir | S - Sale | $36.37 | -75.0K | 3.01M | -2% | -$2.73M |
| M | 2021-09-21 | 2021-09-20 | CERT | Schemick Michael Andrew | CFO | S - Sale | $34.62 | -66.7K | 648.7K | -9% | -$2.31M |
| M | 2021-09-20 | 2021-09-17 | CERT | Choe Jieun W. | CHIEF STRATEGY, MARKETING | S - Sale | $35.76 | -20.0K | 316.7K | -6% | -$715.2K |
| I | 2021-09-14 | 2021-09-13 | CERT | EQT Avatar Parent L.P. | 10% | S - Sale | $29.80 | -13.39M | 45.58M | -23% | -$399.16M |
| 2021-09-14 | 2021-09-13 | CERT | SLAINE MASON P | Dir | S - Sale | $29.80 | -620.7K | 2.12M | -23% | -$18.50M |
Purchase Sale Sale after option exercise All abbreviations